The Role of Resting State Networks Connectivity in Cluster Headache: a HD-EEG Study

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Cluster headache is a highly disabling primary headache disorder, characterized by severe, excruciating, recurrent unilateral headache attacks. Typically, attacks' onset displays a circadian rhythm, and bout recurrence happens in a circannual fashion. Notably, the mechanisms underlying the shift between the remission phase and cluster bout are poorly understood. Thus, the investigators aim to study brain connectivity in episodic cluster headache patients. Additionally, an explorative analysis of functional connectivity in chronic cluster headache patients will be performed.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: t
View:

• Diagnosis of 3.1.1 episodic cluster headache, or 3.1.2 chronic cluster headache, according to the International Classification of Headache Disorders-3 (ICHD-3) criteria

• History of at least 1 year of disease

• For the active-phase recording (T0) in eCH, no preventive medication ongoing or verapamil at a stable dose for at least 2 weeks

• For the remission-phase recording (T1), no preventive medication ongoing, and at least 14 headache-free days since preventive discontinuation

• Age and sex-matched healthy volunteers, without history of headache disorders except sporadic tension-type headache according to ICHD-3 criteria

Locations
Other Locations
Italy
Headache Science & Neurorehabilitation Center
RECRUITING
Pavia
Contact Information
Primary
Cinzia Fattore, MD
cinzia.fattore@mondino.it
0382380385
Backup
Roberto De Icco, MD
roberto.deicco@mondino.it
0382 380425
Time Frame
Start Date: 2021-11-01
Estimated Completion Date: 2025-02
Participants
Target number of participants: 20
Treatments
Healthy subjects
Episodic cluster headache, active
Episodic cluster headache, remission
Chronic cluster headache
Related Therapeutic Areas
Sponsors
Leads: IRCCS National Neurological Institute C. Mondino Foundation

This content was sourced from clinicaltrials.gov